X-102715165-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001004051.4(GPRASP2):āc.296A>Gā(p.Lys99Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000743 in 1,211,702 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000026 ( 0 hom., 1 hem., cov: 24)
Exomes š: 0.0000055 ( 0 hom. 1 hem. )
Consequence
GPRASP2
NM_001004051.4 missense
NM_001004051.4 missense
Scores
1
3
13
Clinical Significance
Conservation
PhyloP100: 1.87
Genes affected
GPRASP2 (HGNC:25169): (G protein-coupled receptor associated sorting protein 2) The protein encoded by this gene is a member of a family that regulates the activity of G protein-coupled receptors (GPCRs). The encoded protein has been shown to be capable of interacting with several GPCRs, including the M1 muscarinic acetylcholine receptor and the calcitonin receptor. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, May 2010]
ARMCX5-GPRASP2 (HGNC:42000): (ARMCX5-GPRASP2 readthrough) This locus represents naturally occurring readthrough transcription among the adjacent armadillo repeat containing, X-linked 5 (ARMCX5), G protein-coupled receptor associated sorting proteins 1 and 2 (GPRASP1 and GPRASP2), basic helix-loop-helix family member b9 (BHLHB9), and long intergenic non-protein coding RNA 630 (LINC00630) genes on chromosome X. Transcripts may make use of multiple alternative promoters and polyadenylation signals in this region. Readthrough transcripts may produce proteins identical to the proteins encoded by GPRASP2 or BHLHB9. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.116488665).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPRASP2 | NM_001004051.4 | c.296A>G | p.Lys99Arg | missense_variant | 5/5 | ENST00000483720.7 | |
ARMCX5-GPRASP2 | NR_146584.3 | n.795+899A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPRASP2 | ENST00000483720.7 | c.296A>G | p.Lys99Arg | missense_variant | 5/5 | 2 | NM_001004051.4 | P1 | |
ARMCX5-GPRASP2 | ENST00000652409.1 | c.-756+899A>G | intron_variant | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 3AN: 113533Hom.: 0 Cov.: 24 AF XY: 0.0000280 AC XY: 1AN XY: 35665
GnomAD3 genomes
AF:
AC:
3
AN:
113533
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
35665
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000328 AC: 6AN: 182676Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67382
GnomAD3 exomes
AF:
AC:
6
AN:
182676
Hom.:
AF XY:
AC XY:
1
AN XY:
67382
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000546 AC: 6AN: 1098169Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 1AN XY: 363545
GnomAD4 exome
AF:
AC:
6
AN:
1098169
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
363545
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000264 AC: 3AN: 113533Hom.: 0 Cov.: 24 AF XY: 0.0000280 AC XY: 1AN XY: 35665
GnomAD4 genome
AF:
AC:
3
AN:
113533
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
35665
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2022 | The c.296A>G (p.K99R) alteration is located in exon 5 (coding exon 1) of the GPRASP2 gene. This alteration results from a A to G substitution at nucleotide position 296, causing the lysine (K) at amino acid position 99 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
FATHMM_MKL
Benign
D
LIST_S2
Benign
.;T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M;M
MutationTaster
Benign
N;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Uncertain
D;D;D
Polyphen
P;P;P
Vest4
MutPred
Loss of ubiquitination at K99 (P = 0.0071);Loss of ubiquitination at K99 (P = 0.0071);Loss of ubiquitination at K99 (P = 0.0071);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at